1107062-37-2

Basic information

• Product Name: 1-(4-(methylsulfonyl)phenoxy)-3-nitro-5-(trifluoromethyl)benzene
• Synonyms: 1-(4-(methylsulfonyl)phenoxy)-3-nitro-5-(trifluoromethyl)benzene
• CAS NO: 1107062-37-2
• Molecular Weight: 361.298
• Mol File: 1107062-37-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-(4-(methylsulfonyl)phenoxy)-3-nitro-5-(trifluoromethyl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-(methylsulfonyl)phenoxy)-3-nitro-5-(trifluoromethyl)benzene(1107062-37-2)
• EPA Substance Registry System: 1-(4-(methylsulfonyl)phenoxy)-3-nitro-5-(trifluoromethyl)benzene(1107062-37-2)

Safety Data

• Hazardous Substances Data: 1107062-37-2(Hazardous Substances Data)

Upstream product

• 14763-60-1 4-methanesulfonyl-phenol 
• 454-73-9 1-fluoro-3-(trifluoromethyl)-5-nitrobenzene 
• 455-15-2 1-(methylsufonyl)-4-fluorobenzene 
• 349-57-5 3-nitro-5-(trifluoromethyl)phenol 

Downstream Products

• 1107062-38-3 C₁₄H₁₂F₃NO₃S 

Relevant articles and documents

COMPOSITIONS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR 2 (S1PR2) BINDING AGENTS AND USES THEREOF

Described are compounds for the binding of S1PR2, and imaging agents and pharmaceutical compositions including said compounds. Also described are methods employing the compounds, imaging agents, and pharmaceutical compositions. These methods include imaging and/or treatment of diseases associated with S1PR2.

NOVEL GLUCOKINASE ACTIVATORS AND METHODS OF USING SAME

Compounds are provided which are activators of the enzyme glucokinase and thus are useful in treating diabetes and related diseases, which compounds have the structure where Q is and R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein or a pharmaceutically acceptable salt thereof. A method for treating diabetes and related diseases employing the above compounds is also provided.